About Viatris, Inc. 
Viatris, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 121 Schemes (42.79%)
Foreign Institutions
Held by 388 Foreign Institutions (11.27%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3,520 Million
(Quarterly Results - Mar 2026)
Net Profit:
176 Million
Pharmaceuticals & Biotechnology
USD 15,347 Million (Mid Cap)
NA (Loss Making)
NA
84.69%
0.89
-0.46%
1.04






